Saturation Targets and Resuscitation in Preterm Trial
STARTPreterm
2 other identifiers
interventional
75
1 country
1
Brief Summary
The purpose of this research project is to determine if use of optimized target oxygen strategy during delivery room resuscitation can reduce oxidative stress in premature newborns. Objective is to compare oxidative stress markers between preterm neonates resuscitated in the delivery room using three different target oxygen strategies. OX50 target oxygen strategy is currently in use and recommended by neonatal resuscitation program. In this strategy oxygen is adjusted to meet the goal transitional saturations which are approximated 50th centile saturations observed in healthy term newborns. In OX25 target oxygen strategy oxygen will be adjusted to meet the goal transitional saturations which are 25th percentile transitional saturations observed in healthy term newborns. In OX75 target oxygen strategy oxygen will be adjusted to meet the goal transitional saturations which are 75th percentile transitional saturations observed in healthy term newborns.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 14, 2017
CompletedFirst Posted
Study publicly available on registry
April 14, 2017
CompletedStudy Start
First participant enrolled
September 20, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2022
CompletedJanuary 4, 2023
December 1, 2022
2 years
March 14, 2017
December 30, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Oxidative Balance Ratio from Baseline
Difference in oxidative balance ratio between Cord blood and postnatal sample obtained within 2 hours of life will be assessed.
within 2 hours after Birth
Secondary Outcomes (11)
Reduction in Isoprostane,Isofluran, 8-OHdG and protein carbonyls
Within 2 hours after birth and at 24 hours
• Reduction in oxygen load in the delivery room
During resuscitation in the delivery room for the first 15 minutes of life
Time spent in goal saturations
During resuscitation in the delivery room
Incidence of bradycardia during resuscitation
During resuscitation in the delivery room
intubation in the delivery room
During resuscitation in the delivery room
- +6 more secondary outcomes
Study Arms (3)
OX25
EXPERIMENTALResuscitation will be initiated at 30% O2. Titration of oxygen during neonatal resuscitation: Intervention is target goal saturations which will be the 10th to 25th percentile saturations observed in healthy term newborns.
OX50
NO INTERVENTIONResuscitation will be initiated with 30% O2 and target goal saturations will be the approximated median SpO2 observed in healthy term newborns as per current NRP guidelines
OX75
ACTIVE COMPARATORResuscitation will be initiated at 30% O2. Titration of oxygen during neonatal resuscitation: Intervention is target goal saturations which will be the 75th percentile saturations observed in healthy term newborns.
Interventions
Resuscitation will be initiated at 30% O2 and target goal saturations will be the 10th to 25th percentile saturations in OX25 and 75th percentile in OX75 group. The control group will be resuscitated with the OX50 strategy in which resuscitation will be initiated with 30% O2 and target goal saturations will be the approximated median SpO2 observed in healthy term newborns as per current NRP guidelines. For the first 6 minutes after birth, target ranges of of all 3 arms are different. After 6 min, the target ranges are are identical.
Eligibility Criteria
You may qualify if:
- Neonates of obstetric gestational age 23-30 weeks
- Inborn at Parkland Hospital, Dallas, Tx
- Resuscitation team present to initiate resuscitation
You may not qualify if:
- Prenatally diagnosed cyanotic congenital heart disease
- Prenatally diagnosed congenital diaphragmatic hernia
- Prenatally diagnosed significant airway anomaly
- Prenatally suspected hypoplasia of lungs
- Preductal saturation cannot be measured
- Non-viable newborns
- Prenatally diagnosed condition due to which decision is made to limit resuscitation in the delivery room by parents and neonatologist.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Parkland Hospital
Dallas, Texas, 75039, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Vishal Kapadia, MD
University of Texas Southwestern Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Clinical care team in the neonatal intensive care unit, investigators running the oxidative stress measurements and investigator assessing neurodevelopmental outcomes will be blinded to which arm the infant was randomized to in the delivery room.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Pediatrics
Study Record Dates
First Submitted
March 14, 2017
First Posted
April 14, 2017
Study Start
September 20, 2017
Primary Completion
September 30, 2019
Study Completion
September 30, 2022
Last Updated
January 4, 2023
Record last verified: 2022-12